*
*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients.
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence NA|Not applicable to my practice
54321
Properly diagnose and manage solid tumor malignancies.
Provide an update of new molecular and targeted treatments being developed for solid tumors.
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
54321
Immunoblative Therapy - Luis Diaz, M.D.
Re-imaging Evolution in the Precision Oncology Paradigm - Vivek Subbiah, M.D.
Precision Oncology In Metastatic Prostate Cancer - Neeraj Agarwal, M.D.
Applying Precision Medicine to Rare Subtypes of Renal Cell Carcinoma - Bradley McGregor, M.D.
AI Transforming Precision Oncology _ Chadi Nabhan, M.D.
Addressing Disparities in Precision Oncology - Ishwaria Subbiah, M.D.
State of the Art Therapeutic Approached in Pancreatic Cancer - Shubham Pant, M.D.
From Targets to Tumors: Redefining Precision in Gastrointestinal Cancers through ADC's - Sarbajit Mukherjee, M.D.
The Role of Precision Medicine in the Management of Ovarian Cancer - Don Dizon, M.D.
Dividing and Conquering Sarcomas - Neeta Somaiah, M.D.
Precision Oncology Approached in Low-Grade Gliomas - Vyshak Venur, M.D.
Precision Oncology Approaches in High Grade Gliomas - Patrick Wen, M.D.
From Pathways to Payloads: Evolving Precision in HR+/HER2-MBC Treatment - Reshma Mahtani, D.O.
*
*
*
*
*
*
*
*